Medical News

RSS

Hyperion enrolls first patient in HPN-100 investigational compound clinical trial

Hyperion Therapeutics today announced that the first patient has been enrolled in a clinical trial of investigational compound HPN-100 (glycerol phenylbutyrate) in children ages 6-17 with urea cycle disorders (UCD). The study will evaluate the safety, tolerability, and ammonia control of glycerol phenylbutyrate compared to BUPHENYL® (sodium phenylbutyrate).

15 Sep 2009

Idera Pharmaceuticals to discuss TLR-targeted drug discovery and development programs

Idera Pharmaceuticals, Inc., a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like Receptors (TLR), today announced that it will discuss its TLR-targeted drug discovery and development programs and provide a general corporate overview at the UBS Global Life Sciences Conference on Monday, September 21, 2009, at 10:30 a.m. EDT at the Grand Hyatt New York Hotel in New York City.

15 Sep 2009

Members of BCBSF to receive coverage for the administration of the H1N1 vaccine

Blue Cross and Blue Shield of Florida, Inc. (BCBSF) announces today its plans to offer coverage for the administration of the H1N1 vaccine to all members when it becomes commercially available to the public. The vaccine administration will be covered for members whose health care plans cover vaccines, as well as for those members whose plans currently do not include immunizations.

15 Sep 2009

HFSA meeting highlights increased risk of heart failure among childhood cancer survivors

The 13th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) today featured a discussion titled "Cardiovascular Disease in Survivors of Childhood Cancer" presented by Dr. Ming Hui Chen, Director, Stress Echocardiography Program and Program for Cardiac Health in Cancer Survivors, Children's Hospital Boston.

15 Sep 2009

American Lung Association urges families to get immunized against seasonal influenza

The American Lung Association is intensifying its seasonal influenza public education initiative to urge families to get vaccinated as soon as possible. The Faces of Influenza campaign aims to ensure Americans get immunized against seasonal influenza, which each year causes an estimated 36,000 deaths and over 226,000 hospitalizations from the virus and its related complications.

15 Sep 2009

Tripos announces a new program for software developers

Tripos™, a leading provider of drug discovery informatics products and services, today announced the creation of a worldwide Benchware® Pantheon™ Partner Program for software developers.

15 Sep 2009

Council briefing series to examine role of public policy in promoting medical innovation

The Council for American Medical Innovation will host a breakfast briefing on Capitol Hill titled "Translational Research - From Bench to Bedside." Health policy experts will explore important changes needed to improve the process of development and approval for safe and effective drugs, biologics, medical devices and diagnostics.

15 Sep 2009

DNC passes a resolution to commend the new direction set to honor America's service members

At this weekend's Democratic National Committee (DNC) meeting in Austin, TX, the full membership of the DNC passed a resolution to commend the new direction set to honor America's service members.

15 Sep 2009

Service Employees International Union illegally collect Kansas healthcare workers' information

The Alliance for Worker Freedom (AWF) calls on Kansas Governor Mark Parkinson (D) to make information available regarding his Department's use of state resources and taxpayer money to obtain personal contact information of healthcare providers on behalf of the Service Employees International Union / SEIU Kansas.

15 Sep 2009

CBI's October Summit to discuss import-export regulation chain safety and security issues

The Center for Business Intelligence (CBI), a division of Advanstar Communications, is pleased to host their October Summit taking place at the Marriott Tyson's Corner, on October 22-23, 2009. Thought leaders from the importing and exporting compliance space from leading pharmaceutical and biotech companies assemble to discuss timely issues surrounding import-export regulation chain safety and security in this industry.

15 Sep 2009

Palatin Technologies to announce clinical trial results of PL-3994

Palatin Technologies, Inc. (NYSE Amex: PTN) announced that a poster on clinical trial results with PL-3994, its product for heart failure, will be presented today at the 13th Annual Scientific Meeting of the Heart Failure Society of America in Boston.

15 Sep 2009

Andersonville Arts Weekend art sales proceeds to support HIV-affected families

During the Arts weekend, over 25 of Olmetti's works and installations will be featured at SIR Spa. Proceeds from art sales will benefit the Chicago House, in support pf the mission of Chicago House and Social Service Agency to provide housing and supportive services to HIV-affected families and individuals who may also be impacted by poverty, homelessness, substance abuse, and mental illness.

15 Sep 2009

iMedicor and Transgenomic to develop an educational marketing program for NuroPro

iMedicor and Transgenomic today announced that they have signed an agreement to develop an educational marketing program for NuroPro, Transgenomic’s diagnostic tests for Alzheimer’s and Parkinson’s disease.

15 Sep 2009

Implantable defibrillator therapy not beneficial for women with heart failure

Implantable cardioverter-defibrillators do not appear to be associated with a reduced risk of death in women with advanced heart failure, according to a meta-analysis of previously published research in the September 14 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

15 Sep 2009

Biocryst signs agreement with three partners to represent its anti-viral peramivir outside U.S.

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has signed binding letters of intent with three partners who will exclusively represent BioCryst and its anti-viral peramivir for influenza stockpiling opportunities, as well as for marketing and distribution of peramivir for seasonal influenza upon local regulatory approval, within their territories outside the U.S.

15 Sep 2009

Tryton Side Branch Stent used in 250 procedures to treat atherosclerotic lesions

Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced today that the company’s Tryton Side Branch Stent has been used in 250 procedures to treat atherosclerotic lesions at a bifurcation in patients with heart disease.

15 Sep 2009

NMQF launches the P.A.D. Atlas database that maps peripheral arterial disease prevalence by zip code

The National Minority Quality Forum (NMQF), one of the nation's leading voices in the health disparities discussion, is launching the P.A.D. Atlas, a database that maps by zip code peripheral arterial disease (P.A.D.) prevalence down to the street level, with the P.A.D. Coalition and support from the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.

15 Sep 2009

Mantra medicine tool helps patients in healing process

Dr. Mitchell Earl Gibson, a board-certified medical doctor in High Point, North Carolina, has formed a company that creates mantra and prayer-meditation-based recordings.

15 Sep 2009

Halozyme Therapeutics to present its product development pipeline

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced its participation in the UBS Global Life Sciences Conference to be held on September 21-23, 2009 in New York City.

15 Sep 2009

Neuroskin Psoriasis Relief DRTV test results announced by avVaa World Health Care

avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the results of its first DRTV test week.

15 Sep 2009

Medical News

Hyperion enrolls first patient in HPN-100 investigational compound clinical trial

Idera Pharmaceuticals to discuss TLR-targeted drug discovery and development programs

Members of BCBSF to receive coverage for the administration of the H1N1 vaccine

HFSA meeting highlights increased risk of heart failure among childhood cancer survivors

American Lung Association urges families to get immunized against seasonal influenza

Tripos announces a new program for software developers

Council briefing series to examine role of public policy in promoting medical innovation

DNC passes a resolution to commend the new direction set to honor America's service members

Service Employees International Union illegally collect Kansas healthcare workers' information

CBI's October Summit to discuss import-export regulation chain safety and security issues

Palatin Technologies to announce clinical trial results of PL-3994

Andersonville Arts Weekend art sales proceeds to support HIV-affected families

iMedicor and Transgenomic to develop an educational marketing program for NuroPro

Implantable defibrillator therapy not beneficial for women with heart failure

Biocryst signs agreement with three partners to represent its anti-viral peramivir outside U.S.

Tryton Side Branch Stent used in 250 procedures to treat atherosclerotic lesions

NMQF launches the P.A.D. Atlas database that maps peripheral arterial disease prevalence by zip code

Mantra medicine tool helps patients in healing process

Halozyme Therapeutics to present its product development pipeline

Neuroskin Psoriasis Relief DRTV test results announced by avVaa World Health Care

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News